Konrad Zaborowski, MD

Maria Sklodowska-Curie National Research Institute of Oncology
Warsaw, Mazowieckie, Poland

Presentation(s):

• Paper 15 - PRIMARY ENDPOINT AND TRANSLATIONAL CORRELATES FROM EFTISARC-NEO: PHASE II TRIAL OF NEOADJUVANT EFTILAGIMOD ALPHA (EFTI), PEMBROLIZUMAB AND RADIOTHERAPY IN PATIENTS WITH RESECTABLE SOFT TISSUE SARCOMA

  Thursday, November 13, 2025
  1:30 PM - 3:00 PM EST

  Disclosure information not submitted.